Skip to main content
Register
Medicine Matters Diabetes
TOOLBAR 1 2 3 4
SEARCH
MENU 1 2 3 4
Close search form
main-content
Top
Print
​
print
​
share

Expert commentary: The HARMONY trial

John Wilding discusses the unexpected results of HARMONY, the albiglutide cardiovascular outcomes study (2:43).

More on this topic

10-02-2018 | Albiglutide | EASD 2018 | News

Albiglutide reduces cardiovascular risk in patients with type 2 diabetes

Version: 20200226085396_0.626.0_76c2f02